The tool — CTS5 (Clinical Treatment Score post-5-years) — was developed with colleagues at The Royal Marsden NHS Foundation Trust and could be used to determine which patients are at high enough risk ...

The Damon Runyon Cancer Research Foundation announced the recipients of 2026 Damon Runyon-Rachleff Innovation Award. March 9, 2026 • By Damon Runyon Cancer Research Foundation ...

Therapeutic vaccines train the immune system to recognize and attack malignant cells.

Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

Our fourth annual Cancer Health 25 honors individuals working tirelessly to define and address such disparities. They include doctors, nurses, researchers, volunteers, patient navigators, grassroots ...

Bishop Stacey Latimer, 63, was diagnosed with metastatic prostate cancer in 2019. He enrolled in a clinical trial and is still going strong.

Meanwhile, across the country, members of the Los Angeles Pink Dragons, trained in the summer for the annual International Dragon Boat festival in Long Beach, California, held in July, and the 10 th ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in ...

Between the end of February and mid-August 2025, this first round of cuts to the NIH disrupted 383 studies testing treatments for cancer, heart disease, brain disease and more. In addition, of 11,008 ...

National Gallbladder and Bile Duct Cancer Awareness Month raises awareness of these less common cancers. According to the American Cancer Society, about 12,300 people are diagnosed with gallbladder ...

In December, the same research group published another study showing a survival benefit for small-cell lung cancer patients who received checkpoint inhibitors before mid-afternoon. A morning advantage ...